Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11638]

A technology that detects breast cancer relapses up to 5 years in advance has been developed

A technology that detects breast cancer relapses up to 5 years in advance has been developed

IGF2BP1: a critical driver of cancer progression and therapeutic target

IGF2BP1: a critical driver of cancer progression and therapeutic target

Botox mitigates debilitating dry mouth in prostate cancer patients receiving radiopharmaceutical therapy

Botox mitigates debilitating dry mouth in prostate cancer patients receiving radiopharmaceutical therapy

The role of fusion genes in cancer development and treatment

The role of fusion genes in cancer development and treatment

Researchers capture first signs of ovarian cancer risk

Researchers capture first signs of ovarian cancer risk

Scientists reveal missing yew tree enzymes needed to make a common cancer drug

Scientists reveal missing yew tree enzymes needed to make a common cancer drug

Mitochondrial ribosomal protein family in cancers: Mechanistic insights and therapeutic implications

Mitochondrial ribosomal protein family in cancers: Mechanistic insights and therapeutic implications

Official BRACELET-1 trial results indicate that adding the oncolytic virus immunotherapy pelareorep to paclitaxel chemotherapy warrants further investigation in HR+ HER2- metastatic breast cancer

Official BRACELET-1 trial results indicate that adding the oncolytic virus immunotherapy pelareorep to paclitaxel...

Epigenetic drivers of liver cancer: unraveling mechanisms behind hepatocellular carcinoma

Epigenetic drivers of liver cancer: unraveling mechanisms behind hepatocellular carcinoma

More women can now get answers about their hereditary risk of breast and ovarian cancer due to new genetic method

More women can now get answers about their hereditary risk of breast and ovarian cancer due to new genetic method

More from ecancer